Evidence map›Paper›PMID 38345631›Full record

ArticleCellular and molecular life sciences : CMLS2024

Platelet C3G: a key player in vesicle exocytosis, spreading and clot retraction.

Cristina Fernández-Infante, Luis Hernández-Cano, Óscar Herranz, Pablo Berrocal, Carmen Sicilia-Navarro, José Ramón González-Porras, José María Bastida, Almudena Porras, Carmen Guerrero

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Assays of Platelet SNARE-actin Interactions.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Cristina Fernández-InfanteInstituto de Biología Molecular y Celular del Cáncer (IMBCC), USAL-CSIC, Centro de Investigación del Cáncer, Campus Unamuno S/N, Salamanca, Spain.
Luis Hernández-Cano *Instituto de Biología Molecular y Celular del Cáncer (IMBCC), USAL-CSIC, Centro de Investigación del Cáncer, Campus Unamuno S/N, Salamanca, Spain.
Óscar Herranz *Instituto de Biología Molecular y Celular del Cáncer (IMBCC), USAL-CSIC, Centro de Investigación del Cáncer, Campus Unamuno S/N, Salamanca, Spain.
Pablo BerrocalInstituto de Biología Molecular y Celular del Cáncer (IMBCC), USAL-CSIC, Centro de Investigación del Cáncer, Campus Unamuno S/N, Salamanca, Spain.
Carmen Sicilia-NavarroInstituto de Biología Molecular y Celular del Cáncer (IMBCC), USAL-CSIC, Centro de Investigación del Cáncer, Campus Unamuno S/N, Salamanca, Spain.
José Ramón González-PorrasInstituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
José María BastidaInstituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
Almudena PorrasDepartamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad Complutense de Madrid, Ciudad Universitaria, Madrid, Spain. maporras@ucm.es.ORCID http://orcid.org/0000-0002-6495-3308
Carmen GuerreroInstituto de Biología Molecular y Celular del Cáncer (IMBCC), USAL-CSIC, Centro de Investigación del Cáncer, Campus Unamuno S/N, Salamanca, Spain. cguerrero@usal.es.ORCID http://orcid.org/0000-0002-8747-6831
Universidad de Salamanca · ESUniversidad Complutense de Madrid · ES

Funding

Consejería de Educación, Junta de Castilla y León SA017U16Consejería de Educación, Junta de Castilla y León SA078P20Ministerio de Ciencia e Innovación PID 2019-104143RB-C21Ministerio de Ciencia e Innovación PID 2019-104143RB-C22Ministerio de Ciencia e Innovación SAF 2016- 76588-C2-1-RMinisterio de Ciencia e Innovación SAF 2016- 76588-C2-2-R
6 · The paper itself

Abstract

C3G is a Rap1 GEF that plays a pivotal role in platelet-mediated processes such as angiogenesis, tumor growth, and metastasis by modulating the platelet secretome. Here, we explore the mechanisms through which C3G governs platelet secretion. For this, we utilized animal models featuring either overexpression or deletion of C3G in platelets, as well as PC12 cell clones expressing C3G mutants. We found that C3G specifically regulates α-granule secretion via PKCδ, but it does not affect δ-granules or lysosomes. C3G activated RalA through a GEF-dependent mechanism, facilitating vesicle docking, while interfering with the formation of the trans-SNARE complex, thereby restricting vesicle fusion. Furthermore, C3G promotes the formation of lamellipodia during platelet spreading on specific substrates by enhancing actin polymerization via Src and Rac1-Arp2/3 pathways, but not Rap1. Consequently, C3G deletion in platelets favored kiss-and-run exocytosis. C3G also controlled granule secretion in PC12 cells, including pore formation. Additionally, C3G-deficient platelets exhibited reduced phosphatidylserine exposure, resulting in decreased thrombin generation, which along with defective actin polymerization and spreading, led to impaired clot retraction. In summary, platelet C3G plays a dual role by facilitating platelet spreading and clot retraction through the promotion of outside-in signaling while concurrently downregulating α-granule secretion by restricting granule fusion.

Indexed as

ActinsBlood PlateletsClot RetractionGuanine Nucleotide-Releasing Factor 2AnimalsExocytosisHemostasisActinsGuanine Nucleotide-Releasing Factor 2Actin polymerizationCoagulationCompound exocytosisGranule secretionPlatelet spreadingRapGEF1Secretome

Identifiers

PMID38345631
PMCPMC10861696
OpenAlexW4391747798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.